COVID-19 vaccine: Are US consumers ready?

The scientific community has made tremendous strides in getting vaccine candidates through clinical development at unprecedented speed to meet the urgent public health need. Conversely, vaccine adoption among minority groups is often lower—for example, in the 2019 through 2020 flu season, 53 percent...

Full description

Saved in:
Bibliographic Details
Published inMcKinsey Insights
Main Authors Apple, Aliza, Azimi, Tara, Cordina, Jenny
Format Magazine Article
LanguageEnglish
Published New York McKinsey & Company, Inc 10.12.2020
Subjects
Adults
Attitudes
Consumers
Coronaviruses
COVID-19
Decision making
Disease transmission
Ethnicity
Herd immunity
Hispanic Americans
Information sources
Minority & ethnic groups
Pandemics
Pneumonia
Polls & surveys
Social networks
Vaccines
United States > US
Online AccessGet full text

Cover

More Information
Summary:The scientific community has made tremendous strides in getting vaccine candidates through clinical development at unprecedented speed to meet the urgent public health need. Conversely, vaccine adoption among minority groups is often lower—for example, in the 2019 through 2020 flu season, 53 percent of non-Hispanic Caucasian adults aged 18 and older got vaccinated, compared with 38 percent of Hispanics and 41 percent of non-Hispanic Black Americans in the same age group. The surveys were conducted only in English. [...]they do not reflect the behavior or attitudes of those who would have preferred a survey in another language. [...]while there are 45 percent cautious adopters today, people can move in and out of this group in either direction over time.
Bibliography:ObjectType-News-1
content type line 24
SourceType-Magazines-1